Terns Pharmaceuticals (TERN) EPS (Basic): 2020-2024
Historic EPS (Basic) for Terns Pharmaceuticals (TERN) over the last 5 years, with Dec 2024 value amounting to -$1.12.
- Terns Pharmaceuticals' EPS (Basic) fell 70.59% to -$0.29 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.27, marking a year-over-year increase of 25.73%. This contributed to the annual value of -$1.12 for FY2024, which is 11.81% up from last year.
- According to the latest figures from FY2024, Terns Pharmaceuticals' EPS (Basic) is -$1.12, which was up 11.81% from -$1.27 recorded in FY2023.
- Terns Pharmaceuticals' EPS (Basic)'s 5-year high stood at -$1.12 during FY2024, with a 5-year trough of -$102.93 in FY2020.
- Over the past 3 years, Terns Pharmaceuticals' median EPS (Basic) value was -$1.27 (recorded in 2023), while the average stood at -$1.35.
- Data for Terns Pharmaceuticals' EPS (Basic) shows a peak YoY spiked of 97.85% (in 2021) over the last 5 years.
- Terns Pharmaceuticals' EPS (Basic) (Yearly) stood at -$102.93 in 2020, then soared by 97.85% to -$2.21 in 2021, then increased by 24.43% to -$1.67 in 2022, then rose by 23.95% to -$1.27 in 2023, then climbed by 11.81% to -$1.12 in 2024.